EDF Health

Joe Chemical — Ring a bell?

Richard Denison, Ph.D., is a Senior Scientist.

I’ve blogged earlier about the chemical industry’s campaign of deception exposed by the Chicago Tribune last month in a jaw-dropping series titled “Playing with Fire.”  That in-depth series ran into the tens of thousands of words and included many extras such as video interviews.

EDF and the Safer Chemicals Healthy Families coalition decided it should be boiled down to its essence.  That’s why we produced this ad, which is running full page today in Politico:

[click to enlarge]

For more on this, check out www.saferchemicals.org/JoeChemical.

 

Also posted in Health policy, Industry influence / Tagged , , , | Comments are closed

Labor and public health advocates to the chemical industry: Stop bullying federal scientists!

Richard Denison, Ph.D., is a Senior Scientist.

After my long post this morning, I’ll keep this one brief:  The United Steelworkers, one of the nation’s top occupational physicians and EDF, represented by Earthjustice, have filed a motion to intervene in D.C. District Court, seeking to help defend the U.S. Department of Health and Human Services’ listing of styrene as “reasonably anticipated to be a human carcinogen.”  The motion is in response to a chemical industry lawsuit attempting to force the agency’s National Toxicology Program to withdraw the styrene warning, which was published in the 12th edition of the Congressionally mandated Report on Carcinogens.

Also posted in Health policy, Industry influence / Tagged , , , | Comments are closed

Striking the right balance between right to know and right to intellectual property protection

Richard Denison, Ph.D., is a Senior Scientist.

There is clearly a need to balance the legitimate claims of companies to protect certain confidential business information (CBI) from public disclosure with the legitimate need for the market, consumers and the public to have access to information they need to make sound decisions about chemicals that are in commerce.  Unfortunately, most of TSCA’s provisions and their implementation by EPA have skewed this balance radically in the direction of denying the public’s right to know and creating an ill-informed chemicals marketplace.

The core problem is two-fold, constituting a vicious circle:  Too many CBI claims are made, and each of the infrequent examinations of such claims done by EPA has found a large fraction to be illegitimate, i.e., not meeting the well-established criteria for what constitutes a legitimate trade secret.  And because of the large number of claims made, EPA has lost the ability to review claims to ensure they are in fact legitimate and remain so over time; this lack of review has led directly to more claims being made, thereby completing the vicious circle.  Read More »

Also posted in Health policy, Regulation / Tagged , , , | Read 2 Responses

Restoring the credibility of risk assessment: A vital need under TSCA reform

Richard Denison, Ph.D., is a Senior Scientist.

The primary means by which chemical risks are to be judged under current legislative proposals for reform of the Toxic Substances Control Act (TSCA), including the Safe Chemicals Act of 2011 (S. 847), is through risk assessment – a key demand of industry.  Yet traditional risk assessments have often fallen short of protecting public health and have sometimes taken decades to identify a “safe” level of exposure to certain chemicals.  As a result, public and health and environmental community confidence in risk assessment is very low.  There are also major technical deficiencies in current risk assessment methodologies that must be addressed if it is to serve as a credible basis for determining chemical risks.  For example, we now know that there are many chemicals for which any level of exposure poses some risk, yet traditional risk assessment assumes a safe level exists for nearly all chemicals.

The Safe Chemicals Act includes provisions to ensure that EPA’s use of risk assessment incorporates the best available science, initially by requiring EPA to rely on the recent recommendations of the nation’s foremost scientific body, the National Academy of Sciences, as to how EPA can improve its practice of risk assessment. Implementing the recommendations is critical to restoring the credibility of and public confidence in risk assessment. Read More »

Also posted in Health policy, Regulation / Tagged , , , , , | Comments are closed

ACC’s chemical prioritization tool: Helpful, but flawed and off the mark for EPA to use without TSCA reform

Richard Denison, Ph.D., is a Senior Scientist.

As I noted in my last post, the American Chemistry Council (ACC) issued its own “prioritization tool” in anticipation of the Environmental Protection Agency’s (EPA) public meetings  to get input on the approach it will use to identify additional chemicals of concern under its Enhanced Chemicals Management Program.

In the context of TSCA reform, various actors in the industry have long called for prioritization, often saying they support EPA’s ability to get off to a quick start on identifying chemicals for further work – only to propose schemes that are more likely to do the opposite.

ACC itself has over time come off as a bit schizophrenic on prioritization, apparently being for it before they were against it.  ACC’s release of its tool puts it squarely back in the pro-prioritization camp, but just what is it proposing?  My sense is it’s after something quite different from what EPA proposes, and frankly, different from what EPA is currently capable of deploying, given its limited authority and resources under TSCA.  In this sense, ACC’s proposal is more relevant in the context of TSCA reform, where we presumably would have an EPA with a mandate to review all chemicals in commerce, the authority to readily get the data it needs, and the resources required to execute the kind of comprehensive prioritization scheme ACC proposes.

But setting that disconnect aside for the moment, let’s delve a bit deeper into the ACC proposal on its own merits.  Read More »

Also posted in Health policy, Regulation / Tagged , , , , , , , | Read 1 Response

Pediatricians: Reform TSCA to protect kids. ACC responds (a la W.C. Fields): We love kids, too

Richard Denison, Ph.D., is a Senior Scientist.

A long-awaited and full-throated endorsement of comprehensive reform of the Toxic Substances Control Act (TSCA) from the venerable American Academy of Pediatricians (AAP) was published online yesterday in the journal Pediatrics.

Right down the line, the AAP’s 8-page policy statement calling for a wholesale overhaul of TSCA mirrors the recommendations of health and environmental advocates, academic researchers and just about anyone else who has paid attention to the mounting body of evidence documenting the linkages between rising chemical exposures and adverse effects on the health of our population, especially the most vulnerable among us:  the developing fetus, infants and young children.

The AAP’s recommendations also closely track key provisions in TSCA reform bills introduced last year in both Houses of Congress as well as the Safe Chemicals Act of 2011 just re-introduced in the U.S. Senate this month.

This latest statement from the Academy adds it to the list of other major medical and health associations that have previously called on Congress to  revamp TSCA, including the American Medical Association, the American Public Health Association and the American Nurses Association.

Given this growing chorus, it is perhaps not surprising that the American Chemistry Council (ACC) would seek to worm its way in to claim that it, too, loves kids and supports TSCA reform.

But dig a bit deeper, and what is most striking is that ACC stridently opposes essentially every element of TSCA reform called for by the American Academy of Pediatrics.  Read More »

Also posted in Health policy / Tagged , , , , , , , , | Comments are closed